Is Core Sci CORZ stock weakening further Q4 2025 Better Than Expected PharmaCyte Biotech PMCB Stock Buy or Sell Is Ingram INGM stock showing recovery signs Ingram posts 65 percent EPS beat on strong B2B tech demand